Pulmonary Sarcoidosis
Dec 22, 2020
Agios’ cancer pipeline auction; uniQure’s gene therapy on hold; Ultragenyx, Mereo Deal; aTyr Pharma Trial
Servier Acquires Agios' Cancer Portfolio in a USD 2 Billion Deal The year is a prime witness of pricey deals and acquisitions in the pharmaceutical industry. To leave its mark, another player decided to hop onto the list. French drugmaker Servier has announced the acquisition of the Oncology business of Agios Ph...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
